THOMAS MONATH to Vaccines
This is a "connection" page, showing publications THOMAS MONATH has written about Vaccines.
Connection Strength
1.252
-
Japanese Encephalitis: Risk of Emergence in the United States and the Resulting Impact. Viruses. 2023 12 28; 16(1).
Score: 0.618
-
Vaccines against diseases transmitted from animals to humans: a one health paradigm. Vaccine. 2013 Nov 04; 31(46):5321-38.
Score: 0.303
-
A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus. J Infect Dis. 2022 04 19; 225(8):1399-1410.
Score: 0.137
-
Exercise-induced serum enzyme elevations confounding the evaluation of investigational drug toxicity. Report of two cases in a vaccine trial. Hum Vaccin. 2005 Jan-Feb; 1(1):24-9.
Score: 0.042
-
Interview with Thomas P. Monath, M.D. Interview by Vicki Glaser. Vector Borne Zoonotic Dis. 2005; 5(3):300-4.
Score: 0.041
-
Limitations of the complement-fixation test for distinguishing naturally acquired from vaccine-induced yellow fever infection in flavivirus-hyperendemic areas. Am J Trop Med Hyg. 1980 Jul; 29(4):624-34.
Score: 0.030
-
Lessons learned from a review of the development of selected vaccines. National Vaccine Advisory Committee. Pediatrics. 1999 Oct; 104(4 Pt 1):942-50.
Score: 0.029
-
Strengthening the biological weapons convention. Science. 1998 Nov 20; 282(5393):1423.
Score: 0.027
-
Epidemic arboviral diseases: priorities for research and public health. Lancet Infect Dis. 2017 03; 17(3):e101-e106.
Score: 0.024